Cystic Fibrosis Mutation Screening CFTR - Del 508 Prenatal Test sale cost 2100 AED
All PCR Panel Cytogenetics and PCR BCR-ABL TEL-AML1 MLL E2A Test sale cost 2300 AED All PCR Panel Cytogenetics and PCR BCR-ABL TEL-AML1 MLL E2A Test Cost 3,000 د.إ Original price was: 3,000 د.إ.2,300 د.إCurrent price is: 2,300 د.إ.
RETT Syndrome Deletion and Duplication Detection Test sale cost 2100 AED RETT Syndrome Deletion and Duplication Detection Test Cost 2,800 د.إ Original price was: 2,800 د.إ.2,100 د.إCurrent price is: 2,100 د.إ.
Sale!

Cystic Fibrosis Mutation Screening CFTR – Del 508 Prenatal Test Cost

Original price was: 2,800 د.إ.Current price is: 2,100 د.إ.

-25%

Cystic Fibrosis (CF) is a genetic disorder that affects the respiratory and digestive systems, leading to severe complications over time. The condition is caused by mutations in the CFTR gene, with the deletion of phenylalanine at position 508 (delF508) being the most common mutation responsible for CF. Early detection of this mutation can significantly impact the management and prognosis of the disease.

The Cystic Fibrosis Mutation Screening CFTR – Del 508 Prenatal Test is a specialized diagnostic procedure aimed at detecting the presence of the delF508 mutation in the fetus during pregnancy. This test is crucial for expectant parents with a family history of Cystic Fibrosis or those identified as carriers of CF mutations, as it helps in making informed decisions regarding the health of their unborn child.

Performed at DNA Labs UAE, a leading facility in genetic testing, this prenatal test offers a reliable means of identifying the delF508 mutation. The test cost is set at 2100 AED, reflecting the comprehensive analysis and expertise involved in delivering accurate results. By opting for this prenatal screening, parents can gain early insights into their child’s genetic health, paving the way for prompt interventions and support if needed.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Cystic Fibrosis Mutation Screening CFTR – Del 508 Prenatal Test

Test Name: Cystic Fibrosis mutation screening CFTR – Del 508 Prenatal Test

Components: Sterile container / Sterile Normal Saline Container / EDTA Vacutainer (2ml)

Price: 2100.0 AED

Sample Condition: Amniotic fluid / Chorionic villi / Cord blood

Report Delivery: 7-8 days

Method: Sanger Sequencing

Test Type: Genetics

Doctor: Gynecologist

Test Department: Pre Test Information

Cystic Fibrosis mutation screening (CFTR – Del 508) Prenatal can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

Cystic Fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene. One of the most common mutations associated with CF is the deletion of three nucleotides (Del 508) in the CFTR gene. This mutation leads to the production of a defective CFTR protein, which affects the normal functioning of the respiratory, digestive, and reproductive systems.

Prenatal screening for the CFTR – Del 508 mutation is performed to identify whether a fetus has inherited this specific mutation from their parents. This screening is usually recommended for couples who have a family history of CF or are carriers of CFTR gene mutations.

There are several methods available for prenatal CF mutation screening, including:

  1. Chorionic villus sampling (CVS): This procedure involves the removal of a small sample of cells from the placenta. These cells are then analyzed to determine if the CFTR – Del 508 mutation is present.
  2. Amniocentesis: In this procedure, a small amount of amniotic fluid is extracted from the amniotic sac surrounding the fetus. The cells in the fluid are then tested for the CFTR – Del 508 mutation.
  3. Non-invasive prenatal testing (NIPT): This is a newer screening method that involves analyzing the fetal DNA present in the mother’s blood. NIPT can detect the presence of specific genetic mutations, including the CFTR – Del 508 mutation.

The results of prenatal CF mutation screening can help parents make informed decisions about their pregnancy and plan for the future. If the fetus is found to have inherited the CFTR – Del 508 mutation, further diagnostic testing may be recommended to confirm the diagnosis.

It is important to note that CF is a complex disorder caused by various mutations in the CFTR gene. While the CFTR – Del 508 mutation is the most common, there are many other mutations that can cause CF. Therefore, prenatal screening for CF should ideally include testing for a panel of CFTR gene mutations to provide a comprehensive assessment of the risk.

Test Name Cystic Fibrosis mutation screening CFTR – Del 508Prenatal Test
Components Sterile container / Sterile Normal Saline Container / EDTA Vacutainer (2ml)
Price 2100.0 AED
Sample Condition Amniotic fluid \/ Chorionic villi \/ Cord blood
Report Delivery 7-8 days
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information Cystic Fibrosis mutation screening (CFTR – Del 508) Prenatal ] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Cystic Fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene. One of the most common mutations associated with CF is the deletion of three nucleotides (Del 508) in the CFTR gene. This mutation leads to the production of a defective CFTR protein, which affects the normal functioning of the respiratory, digestive, and reproductive systems.

Prenatal screening for the CFTR – Del 508 mutation is performed to identify whether a fetus has inherited this specific mutation from their parents. This screening is usually recommended for couples who have a family history of CF or are carriers of CFTR gene mutations.

There are several methods available for prenatal CF mutation screening, including:

1. Chorionic villus sampling (CVS): This procedure involves the removal of a small sample of cells from the placenta. These cells are then analyzed to determine if the CFTR – Del 508 mutation is present.

2. Amniocentesis: In this procedure, a small amount of amniotic fluid is extracted from the amniotic sac surrounding the fetus. The cells in the fluid are then tested for the CFTR – Del 508 mutation.

3. Non-invasive prenatal testing (NIPT): This is a newer screening method that involves analyzing the fetal DNA present in the mother’s blood. NIPT can detect the presence of specific genetic mutations, including the CFTR – Del 508 mutation.

The results of prenatal CF mutation screening can help parents make informed decisions about their pregnancy and plan for the future. If the fetus is found to have inherited the CFTR – Del 508 mutation, further diagnostic testing may be recommended to confirm the diagnosis.

It is important to note that CF is a complex disorder caused by various mutations in the CFTR gene. While the CFTR – Del 508 mutation is the most common, there are many other mutations that can cause CF. Therefore, prenatal screening for CF should ideally include testing for a panel of CFTR gene mutations to provide a comprehensive assessment of the risk.

SKU: TEST-4866 Category:

Related products